The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
A Odermatt - American Journal of Physiology-Renal …, 2011 - journals.physiology.org
The Western-style diet is characterized by its highly processed and refined foods and high
contents of sugars, salt, and fat and protein from red meat. It has been recognized as the …
contents of sugars, salt, and fat and protein from red meat. It has been recognized as the …
Role of triglyceride-rich lipoproteins in diabetic nephropathy
JC Rutledge, KF Ng, HH Aung… - Nature Reviews …, 2010 - nature.com
Diabetic nephropathy is an increasingly important cause of morbidity and mortality
worldwide. A large body of evidence suggests that dyslipidemia has an important role in the …
worldwide. A large body of evidence suggests that dyslipidemia has an important role in the …
Streptozotocin‐induced diabetic models in mice and rats
BL Furman - Current protocols in pharmacology, 2015 - Wiley Online Library
Streptozotocin (STZ) is an antibiotic that produces pancreatic islet β‐cell destruction and is
widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed …
widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed …
Streptozotocin‐induced diabetic models in mice and rats
BL Furman - Current protocols, 2021 - Wiley Online Library
Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β‐cell destruction and is
widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed …
widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed …
[HTML][HTML] San-Huang-Yi-Shen capsule ameliorates diabetic nephropathy in mice through inhibiting ferroptosis
S Lv, H Li, T Zhang, X Su, W Sun, Q Wang… - Biomedicine & …, 2023 - Elsevier
Diabetic nephropathy (DN) is one of the main complications of diabetes. However, effective
therapy to block or slow down the progression of DN is still lacking. San-Huang-Yi-Shen …
therapy to block or slow down the progression of DN is still lacking. San-Huang-Yi-Shen …
Cytochrome P450 eicosanoids in hypertension and renal disease
Cytochrome P450 eicosanoids in hypertension and renal diseas... : Current Opinion in
Nephrology and Hypertension Cytochrome P450 eicosanoids in hypertension and renal disease …
Nephrology and Hypertension Cytochrome P450 eicosanoids in hypertension and renal disease …
Effect of cytochrome P450 metabolites of arachidonic acid in nephrology
Thirty-five years ago, a third pathway for the metabolism of arachidonic acid by cytochrome
P450 enzymes emerged. Subsequent work revealed that 20-hydroxyeicosatetraenoic and …
P450 enzymes emerged. Subsequent work revealed that 20-hydroxyeicosatetraenoic and …
The transcriptional regulation of the human CYP2C genes
Y Chen, JA Goldstein - Current drug metabolism, 2009 - ingentaconnect.com
In humans, four members of the CYP2C subfamily (CYP2C8, CYP2C9, CYP2C18, and
CYP2C19) metabolize more than 20% of all therapeutic drugs as well as a number of …
CYP2C19) metabolize more than 20% of all therapeutic drugs as well as a number of …
Eicosanoids, β-cell function, and diabetes
P Luo, MH Wang - Prostaglandins & other lipid mediators, 2011 - Elsevier
Arachidonic acid (AA) is metabolized by cyclooxygenase (COX), lipoxygenase (LOX), and
cytochrome P450 (CYP) enzymes into eicosanoids, which are involved in diverse diseases …
cytochrome P450 (CYP) enzymes into eicosanoids, which are involved in diverse diseases …
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
XJ Li, P Suo, YN Wang, L Zou, XL Nie… - Frontiers in …, 2024 - frontiersin.org
Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly
metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and …
metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and …